Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

CervoMed (CRVO) Equity Ratio (2022 - 2025)

Historic Equity Ratio for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to 0.85.

  • CervoMed's Equity Ratio fell 898.06% to 0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85, marking a year-over-year decrease of 898.06%. This contributed to the annual value of 0.91 for FY2024, which is 2301.51% up from last year.
  • Latest data reveals that CervoMed reported Equity Ratio of 0.85 as of Q3 2025, which was down 898.06% from 0.88 recorded in Q2 2025.
  • Over the past 5 years, CervoMed's Equity Ratio peaked at 0.94 during Q2 2024, and registered a low of 10.44 during Q2 2023.
  • Its 4-year average for Equity Ratio is 1.11, with a median of 0.88 in 2025.
  • The largest annual percentage gain for CervoMed's Equity Ratio in the last 5 years was 10923.99% (2023), contrasted with its biggest fall of 124209.63% (2023).
  • CervoMed's Equity Ratio (Quarter) stood at 8.01 in 2022, then soared by 109.24% to 0.74 in 2023, then grew by 23.02% to 0.91 in 2024, then decreased by 6.62% to 0.85 in 2025.
  • Its last three reported values are 0.85 in Q3 2025, 0.88 for Q2 2025, and 0.9 during Q1 2025.